Artificial Intelligence Development for Colorectal Polyp Diagnosis
Development of a Novel Real Time Computer Assisted Colonoscopy Diagnostic Tool for Colorectal Polyps: Lesion Diagnosis and Personalised Patient Management
1 other identifier
observational
4,000
1 country
1
Brief Summary
Accurate classification of growths in the large bowel (polyps) identified during colonoscopy is imperative to inform the risk of colorectal cancer. Reliable identification of the cancer risk of individual polyps helps determine the best treatment option for the detected polyp and determine the appropriate interval requirements for future colonoscopy to check the site of removal and for further polyps elsewhere in the bowel. Current advanced endoscopic imaging techniques require specialist skills and expertise with an associated long learning curve and increased procedure time. It is for these reasons that despite being introduced in clinical practice, uptake of such techniques is limited and current methods of polyp risk stratification during colonoscopy without Artificial intelligence (AI) is suboptimal. Approximately 25% of bowel polyps that are removed by major surgery are analysed and later proved to be non-cancerous polyps that could have been removed via endoscopy thus avoiding anatomy altering surgery and the associated risks. With accurate polyp diagnosis and risk stratification in real time with AI, such polyps could have been removed non-surgically (endoscopically). Current Computer Assisted Diagnosis (CADx, a form of AI) platforms only differentiate between cancerous and non cancerous polyps which is of limited value in providing a personalised patient risk for colorectal cancer. The development of a multi-class algorithm is of greater complexity than a binary classification and requires larger training and validation datasets. A robust CADx algorithm should also involve global trainable data to minimise the introduction of bias. It is for these reasons that this is a planned international multicentre study. The Investigators aim to develop a novel AI five class pathology prediction risk prediction tool that provides reliable information to identify cancer risk independent of the endoscopists skill. These 5 categories are chosen because treatment options differ according to the polyp type and future check colonoscopy guidelines require these categories
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 4, 2024
CompletedFirst Submitted
Initial submission to the registry
May 7, 2024
CompletedFirst Posted
Study publicly available on registry
June 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
ExpectedJune 6, 2024
June 1, 2024
1.1 years
May 7, 2024
June 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
To achieve an overall accuracy of 85% for the five-classification lesion prediction algorithm.
Sensitivity and Specificity
24 months
Positive and negative predicted value
Assess the accuracy to the trained device
24 months
Secondary Outcomes (4)
Interobserver agreement of the endoscopists' prediction of histology of polyps during the annotation process.
36 months
Sub-analysis of the polyp characteristics focused on different gender and ethnicity.
36 months
This will be a sub analysis of an AI algorithm that is trained to predict polyp histology using the prospective data cohort.
36 months
Learned effects of AI augmented endoscopy on endoscopist optical diagnosis
36 months
Interventions
No intervention required from this study, however images will be obtained from patient presenting for colonoscopy
Eligibility Criteria
All adult (over 18 years) presenting for screening or symptomatic colonoscopy
You may not qualify if:
- Unable to provide informed consent.
- Colitis Associated Dysplasia
- Polyps at surgical anastomosis sites
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King's College Hospital NHS Foundation Trust
London, SE5 9RS, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2024
First Posted
June 6, 2024
Study Start
May 4, 2024
Primary Completion
June 1, 2025
Study Completion (Estimated)
May 30, 2026
Last Updated
June 6, 2024
Record last verified: 2024-06